Daniel Hawkins , CEO at Avail Medsystems, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss his company’s telepresence and growing network of practitioners, experts, tech advisors and proctors; eliminating physical barriers and inefficiencies to create more freedom for the clinician’s hands to reach more patients faster; his technology’s ability to bring vital staff into the operating room from a remote location, provide device support, surgical expertise and a network of experts to choose from; traveling 1/4 of a million miles for a single company in one year, meeting his own clinical need in order to inform the design of an innovative technology, raising 150 million in an accelerated demand for Avail’s remote telemedical services, helping to set right the unfortunate data that shows 50-60 percent of a practitioner’s time is spent on logistics, and how the word "avail" is perfect for his company- employing both meanings of the word.
Benjamin Glenn is nationally recognized innovation strategist, speaker and coach based in the Silicon Valley. His work is keenly focused on helping entrepreneurs and innovators in enterprises big and small in our regulated industries identify, develop and maintain competitive advantages. Particularly with regard to our rapidly evolving health care sector, Benjamin's work is highlighted in Biodesign: The Process of Innovating Medical Technologies, a program he has served for over a decade.
Benjamin strongly believes in the increasing importance, and even the necessity, of creating and training a while array of multi-disciplinary teams. Benjamin's passionate presentations often focus on how professionals from different disciplines can successfully work together to create the products and services of the modern economy.
In his presentations, Benjamin draws on his diverse experiences growing up in Texas, serving in the military and working as a Silicon Valley patent attorney. His unique, humorous and often metaphor-ladened insights also draw from over two decades of advising clients on strategic, commercial, innovation and product development issues. As a result, his engaging style has inspired and entertained audiences at leading innovation and entrepreneurial programs nationwide including:
Stanford University BioDesign Program, UC San Francisco, Johns Hopkins University and Northwestern University, along with accelerator and incubator programs such as Matter Chicago, Texas Medical Center’s TMCx, South By SouthWest, VentureWell, Village Capital, Kauffman Foundation, Singularity University, and MedTech Innovator.
Benjamin Glenn is nationally recognized innovation strategist, speaker and coach based in the Silicon Valley. His work is keenly focused on helping entrepreneurs and innovators in enterprises big and small in our regulated industries identify, develop and maintain competitive advantages. Particularly with regard to our rapidly evolving health care sector, Benjamin's work is highlighted in Biodesign: The Process of Innovating Medical Technologies, a program he has served for over a decade.
Benjamin strongly believes in the increasing importance, and even the necessity, of creating and training a while array of multi-disciplinary teams. Benjamin's passionate presentations often focus on how professionals from different disciplines can successfully work together to create the products and services of the modern economy.
In his presentations, Benjamin draws on his diverse experiences growing up in Texas, serving in the military and working as a Silicon Valley patent attorney. His unique, humorous and often metaphor-ladened insights also draw from over two decades of advising clients on strategic, commercial, innovation and product development issues. As a result, his engaging style has inspired and entertained audiences at leading innovation and entrepreneurial programs nationwide including:
Stanford University BioDesign Program, UC San Francisco, Johns Hopkins University and Northwestern University, along with accelerator and incubator programs such as Matter Chicago, Texas Medical Center’s TMCx, South By SouthWest, VentureWell, Village Capital, Kauffman Foundation, Singularity University, and MedTech Innovator.
CEO of Avail Medsystems, a company building the only purpose-built HW/SW SaaS-based network to allow the medical device industry and outside physician advisors to be present in procedure rooms digitally rather than physically, thereby enhancing access to clinical collaboration and training while mitigating infection risk and lowering costs.
Prior to founding Avail, Daniel held roles in both large and emerging companies including Advanced Cardiovascular Systems, Inc. (NYSE: ABT), Endologix (NASDAQ: ELGX), Restore Medical (NYSE: MDT - acq.), EnteroMedics (NASDAQ: ETRM), and Intuitive Surgical (NASDAQ: ISRG) where he joined as the 6th employee. Daniel is a co-founder of Calibra Medical (CeQur - acq.), and founder of Shockwave Medical, Inc. (NASDAQ: SWAV), where he invented Intravascular Lithotripsy (IVL) and served as CEO. A graduate of the Stanford Graduate School of Business, he is a named inventor on over 160 patents and applications and twice named one of the "100 most Intriguing Entrepreneurs" by Goldman Sachs.
CEO of Avail Medsystems, a company building the only purpose-built HW/SW SaaS-based network to allow the medical device industry and outside physician advisors to be present in procedure rooms digitally rather than physically, thereby enhancing access to clinical collaboration and training while mitigating infection risk and lowering costs.
Prior to founding Avail, Daniel held roles in both large and emerging companies including Advanced Cardiovascular Systems, Inc. (NYSE: ABT), Endologix (NASDAQ: ELGX), Restore Medical (NYSE: MDT - acq.), EnteroMedics (NASDAQ: ETRM), and Intuitive Surgical (NASDAQ: ISRG) where he joined as the 6th employee. Daniel is a co-founder of Calibra Medical (CeQur - acq.), and founder of Shockwave Medical, Inc. (NASDAQ: SWAV), where he invented Intravascular Lithotripsy (IVL) and served as CEO. A graduate of the Stanford Graduate School of Business, he is a named inventor on over 160 patents and applications and twice named one of the "100 most Intriguing Entrepreneurs" by Goldman Sachs.
Daniel Hawkins , CEO at Avail Medsystems, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss his company’s telepresence and growing network of practitioners, experts, tech advisors and proctors; eliminating physical barriers and inefficiencies to create more freedom for the clinician’s hands to reach more patients faster; his technology’s ability to bring vital staff into the operating room from a remote location, provide device support, surgical expertise and a network of experts to choose from; traveling 1/4 of a million miles for a single company in one year, meeting his own clinical need in order to inform the design of an innovative technology, raising 150 million in an accelerated demand for Avail’s remote telemedical services, helping to set right the unfortunate data that shows 50-60 percent of a practitioner’s time is spent on logistics, and how the word "avail" is perfect for his company- employing both meanings of the word.
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy